ExploreWatchlistsPricing
  1. JP-listed companies
  2. 3-D Matrix,Ltd.
  3. Financials
  4. Net income

3-D Matrix,Ltd. (7777)

Market cap
¥55B
P/E ratio
59.5x
Three-D Matrix develops and sells medical devices and pharmaceuticals using exclusive MIT-licensed self-assembling peptide technology for surgery, tissue regeneration, and drug delivery.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndNet income (Million JPY)YoY (%)
Apr 30, 2025-2,501+878.94%
Apr 30, 2024-256-89.55%
Apr 30, 2023-2,446+29.09%
Apr 30, 2022-1,895-5.86%
Apr 30, 2021-2,013-35.00%
Apr 30, 2020-3,096+21.20%
Apr 30, 2019-2,555+36.88%
Apr 30, 2018-1,866+34.01%
Apr 30, 2017-1,393-43.38%
Apr 30, 2016-2,459+23.28%
Apr 30, 2015-1,995+86.79%
Apr 30, 2014-1,068+32.75%
Apr 30, 2013-805-308.59%
Apr 30, 2012386

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat